A Systematic Review of CD34+ Stem Cell Therapy as an Innovative and Efficient Treatment for the Management of Refractory Angina-Reference-Cited by-同舟云学术

A Systematic Review of CD34+ Stem Cell Therapy as an Innovative and Efficient Treatment for the Management of Refractory Angina

Published:2022-12-18 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Vithani Vruti,Sutariya Bansi,Montenegro Diana M,Chukwu Michael,Ehsan Paghunda,Aburumman Rawia N,Muthanna Shivani Ishwarya,Menon Swathi Radhakrishnan,Penumetcha Sai Sri

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference24 articles.

1. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials;Henry TD;Eur Heart J,2018

2. CD34(+) cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina;Johnson GL;Stem Cells Transl Med,2020

3. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials;Velagapudi P;Cardiovasc Revasc Med,2019

4. IMPROvE-CED trial: Intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and nonobstructive coronary arteries;Corban MT;Circ Res,2022

5. Angiogenic CD34 stem cell therapy in coronary microvascular repair: A systematic review;Rai B;Cells,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CD34/CD309 expression in circulating endothelial progenitor cells on prognosis and response to bortezomib therapy in multiple myeloma;Journal of Immunoassay and Immunochemistry;2024-08-13